文献速递主动脉疾病

STABLE I研究:复合器械腔内修复复杂B型主动脉夹层的5年结果

Five-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design.
PubMed 文献 · J Vasc Surg · 2019-05-28

STABLE I是一项前瞻性单臂多中心研究,纳入86例复杂B型主动脉夹层患者,使用Zenith夹层腔内系统(近端覆膜支架联合远端裸金属支架)治疗。5年随访显示急性期与非急性期患者的全因死亡率和夹层相关死亡率均较低且无显著差异,主动脉重塑在胸腹主动脉均见改善。

要点

  • 复合器械腔内修复复杂B型主动脉夹层5年全因死亡率急性期79.9%±6.2%免于死亡,非急性期70.1%±8.4%。
  • 5年夹层相关死亡率免于事件率急性期83.9%±5.9%,非急性期90.1%±5.9%,两组相似。
  • 胸主动脉假腔完全血栓化5年时急性期74.1%,非急性期58.8%,真腔扩大假腔缩小。

核心结论

  • 复合器械腔内修复复杂B型主动脉夹层30天全因死亡率低,随访期间夹层相关死亡率低。
  • 急性期与非急性期患者临床结局相似,胸腹主动脉重塑均获有利改善。

研究设计与样本

  • 前瞻性、单臂、多中心研究,2007至2012年在美国、欧洲和澳大利亚入组86例患者(平均年龄59岁,73%男性)。
  • 急性期(症状发作≤14天)55例,非急性期(>14天且≤90天)31例,5年临床和影像随访率88.5%。

主要发现

  • 30天全因死亡率急性期5.5%(3/55),非急性期3.2%(1/31),P>.99。
  • 5年免于全因死亡率急性期79.9%±6.2%,非急性期70.1%±8.4%,P=.40。
  • 5年免于夹层相关死亡率急性期83.9%±5.9%,非急性期90.1%±5.9%,P=.55。
  • 5年胸主动脉假腔完全血栓化急性期74.1%,非急性期58.8%。
  • 5年免于二次干预率急性期65.5%±7.5%,非急性期71.2%±9.0%,P=.71。

关键数值与推荐

  • 5年时胸主动脉横径稳定或缩小者急性期65.5%,非急性期81.3%。
  • 5年时腹主动脉横径稳定或缩小者急性期48.3%,非急性期76.5%。
  • 从术前至5年,急性和非急性期患者胸腹主动脉最大径层面的真腔直径增加、假腔直径减小。

临床怎么用

  • 对于复杂B型主动脉夹层,可考虑使用近端覆膜支架联合远端裸金属支架的复合器械进行腔内修复。
  • 急性期与非急性期患者均可从该治疗中获益,需长期影像随访评估主动脉重塑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We report the final 5-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study, a prospective, single-arm, multicenter study of the Zenith Dissection Endovascular System (William Cook Europe, Aps, Bjaeverskov, Denmark), a pathology-specific device comprising a proximal stent graft with barbs and a distal bare stainless steel stent for the treatment of patients with complicated type B aortic dissection. METHODS: The study prospectively enrolled 86 patients (mean age, 59 years; 73% male) at sites in the United States, Europe, and Australia from 2007 to 2012. Treatment occurred during the acute phase (≤14 days after symptom onset) in 55 patients and during the nonacute phase (>14 days; all treated ≤90 days) in 31 patients. Five-year clinical and imaging follow-up was available for 88.5% of eligible patients. RESULTS: The 30-day all-cause mortality rate was 5.5% (3 of 55) for acute and 3.2% (1 of 31) for nonacute patients (P > .99). The 5-year freedom from all-cause mortality was 79.9% ± 6.2% for acute and 70.1% ± 8.4% for nonacute patients (log-rank test, P = .40). The 5-year freedom from dissection-related mortality (including deaths of indeterminate relatedness to dissection repair) was 83.9% ± 5.9% for acute and 90.1% ± 5.9% for nonacute patients (log-rank test, P = .55). Complete false lumen thrombosis in the thoracic aorta increased over time and was observed in 74.1% of acute and in 58.8% of nonacute patients at 5 years. From preprocedure through 5 years, there was an overall increase in true lumen diameter and a concomitant decrease in false lumen diameter in both acute and nonacute patients at the level of the largest diameter in both the thoracic and abdominal aortas. At 5 years, 65.5% of acute and 81.3% of nonacute patients exhibited a stable or shrinking transaortic diameter in the thoracic aorta, and 48.3% of acute and 76.5% of nonacute patients had a stable or shrinking transaortic diameter in the abdominal aorta. Freedom from secondary intervention at 5 years was 65.5% ± 7.5% for acute and 71.2% ± 9.0% for nonacute patients (log-rank test, P = .71). CONCLUSIONS: Endovascular repair of complicated type B aortic dissection with a composite device design demonstrated low all-cause mortality at 30 days, as well as low dissection-related mortality throughout follow-up. Overall, the acute and nonacute cohorts appeared to respond similarly to treatment involving use of the stent-graft and bare metal stent, demonstrating similar clinical outcomes and favorable improvement in aortic remodeling in the thoracic and abdominal aortas.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lombardi JV, Cambria RP, Nienaber CA, et al. Five-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2019. PMID: 31147139. doi:10.1016/j.jvs.2019.01.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。